Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on August 7, 2014. The report discloses material changes in corporate governance and executive leadership effective as of the close of business on August 8, 2014.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure of CFO and Director: Jay Moyes resigned as Chief Financial Officer and as a member of the Board of Directors. The resignation was not the result of any disagreements with the Company regarding operations, policies, or practices.
- Appointment of Principal Accounting Officer: Gordon Esplin, previously the Vice President of Finance since November 2012, was appointed as the Principal Accounting Officer. Mr. Esplin joined the Company in 2007 as Controller.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies were disclosed in this report other than the standard disclosure that there are no family relationships between Mr. Esplin and other directors or officers, and no material transactions involving Mr. Esplin requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the effective date of Jay Moyes's resignation (August 8, 2014).
- Confirm the new appointment of Gordon Esplin as Principal Accounting Officer.
- Review subsequent filings for the appointment of a new Chief Financial Officer and Board member to replace Mr. Moyes.
- Note that this filing does not address the company's financial health or operational status.